OMNIA MAHMOUD: Open Payments
NPI 1568147478 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 19 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $141 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 4 | $69 |
| IMMUNITYBIO, INC. | 4 | $66 |
| Janssen Biotech, Inc. | 3 | $62 |
| Medtronic, Inc. | 2 | $52 |
| Boston Scientific Corporation | 1 | $38 |
| Antares Pharma, Inc. | 1 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| TOLMAR, INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| COLOPLAST CORP | 1 | $15 |
Products named: ADSTILADRIN, ANKTIVA, ERLEADA, SpaceOAR VUE System - 10mL, XYOSTED, INTERSTIM, ALTAVIVA, GIVLAARI.
Industry payments across NY — which companies pay providers there.
